Walid L. Shaib
0000-0001-9388-0446
Publication & Citation Trends
Most Cited Works
Publications
189 total
Telotristat ethyl to promote weight stability in patients with advanced pancreatic cancer.
Cited by 0
Semantic Scholar
A Case Series of Choroidal and Orbital Neuroendocrine Tumors: Metastasis
Cited by 0
Semantic Scholar
Abstract CT136: Phase Ib study of siltuximab and spartalizumab in advanced pancreatic cancer
Cited by 3
Semantic Scholar
Nipavect: Phase II study of niraparib and panitumumab in advanced RAS WT colorectal cancer.
Cited by 4
Semantic Scholar
OniLon: Phase II trial of trifluridine/tipiracil (TAS-102) and nanoliposomal irinotecan (nal-IRI) in advanced colorectal cancer.
Cited by 1
Semantic Scholar
ASO Visual Abstract: FOLFIRINOX or Gemcitabine Based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-Institutional, Patient-Level Meta-Analysis and Systematic Review
Cited by 0
Semantic Scholar
Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer OA
Cited by 27
Semantic Scholar
Phase II randomised, double-blind study of mFOLFIRINOX plus ramucirumab versus mFOLFIRINOX plus placebo in advanced pancreatic cancer patients (HCRN GI14-198).
Cited by 7
Semantic Scholar
Research Topics
Pancreatic and Hepatic Oncology Research
(47)
Colorectal Cancer Treatments and Studies
(39)
Neuroendocrine Tumor Research Advances
(27)
Cholangiocarcinoma and Gallbladder Cancer Studies
(27)
Cancer Genomics and Diagnostics
(24)
Frequent Co-Authors
Affiliations
Yale New Haven Hospital
Emory Healthcare
Emory University
Emory University Hospital
Cancer Institute (WIA)